Literature DB >> 20022912

Microbicide offers no protection against HIV infection.

Bob Roehr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022912     DOI: 10.1136/bmj.b5538

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.

Authors:  Youssef Gali; Olivier Delezay; Joachim Brouwers; Noura Addad; Patrick Augustijns; Thomas Bourlet; Hind Hamzeh-Cognasse; Kevin K Ariën; Bruno Pozzetto; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.

Authors:  Lin Li; Suiyi Tan; Hong Lu; Lu Lu; Jie Yang; Hong Jin; Shuwen Liu; Shibo Jiang
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04-15       Impact factor: 3.731

3.  3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1.

Authors:  Lin Li; Lili He; Suiyi Tan; Xinhua Guo; Hong Lu; Zhi Qi; Chungen Pan; Xiuli An; Shibo Jiang; Shuwen Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

4.  New Success With Microbicides and Pre-Exposure Prophylaxis for Human Immunodeficiency Virus (HIV): Is Female-Controlled Prevention the Answer to the HIV Epidemic?

Authors:  Jessica Opoku-Anane; Khady Diouf; Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2012

5.  Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmission.

Authors:  Min Qiu; Qin Wang; Ying Chu; Zhongping Yuan; Hongyong Song; Zhiwei Chen; Zhiwei Wu
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment.

Authors:  Frank Wegmann; George Krashias; Kerstin Lühn; Karoliina Laamanen; Sueli Vieira; Simon A Jeffs; Robin J Shattock; Quentin J Sattentau
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

Review 7.  Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.

Authors:  K O François; J Balzarini
Journal:  Med Res Rev       Date:  2010-06-23       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.